We also proposed an eight-gene signature comprising AMH, WBSCR28, SFTA2, MYH2, POU4F1, SIX4, PGPEP1L, and PAX5, which would provide directive significance for prognostic prediction and treatment selection in CRC. This evidence concerns the gene AMH and colorectal carcinoma.